A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy
Clinical trial NCT07675811 · RECRUITING
Trial details
- NCT number
- NCT07675811
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-05-31
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.